Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Operating Expenses | 6,718 | 4,898 | 6,263 | 15,617 | 5,431 |
| Operating Income | -6,718 | -4,898 | -6,263 | -15,617 | -5,431 |
| Other Income | 222 | 669 | 1,150 | 883 | 685 |
| Pre-tax Income | -6,496 | -4,229 | -5,113 | -14,734 | -4,746 |
| Net Income Continuous | -6,496 | -4,229 | -5,113 | -14,734 | -4,746 |
| Net Income | $-6,496 | $-4,229 | $-5,113 | $-14,734 | $-4,746 |
| EPS Basic Total Ops | -0.90 | -0.60 | -0.70 | -2.20 | -0.70 |
| EPS Basic Continuous Ops | -0.86 | -0.56 | -0.67 | -2.12 | -0.72 |
| EPS Diluted Total Ops | -0.90 | -0.60 | -0.70 | -2.20 | -0.70 |
| EPS Diluted Continuous Ops | -0.86 | -0.56 | -0.67 | -2.12 | -0.72 |
| EBITDA(a) | $-6,373 | $-4,578 | $-6,001 | $-15,388 | $-5,178 |